# Judo Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/judo-bio

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.judo.bio/
- Total disclosed funding: $45M
- Latest round: Series A (Jul 31, 2024)
- Investors on record: 7

## About

Established in 2021 and based in Massachusetts, US, Judo Bio Inc. is a biotechnology company that develops oligonucleotide medicines targeting kidney diseases. In October 2024, the firm raised an amount of USD 25 million in series A funding co-led by returning investor Atlas Venture and investors TCG and DROIA Ventures, with participation from other investors Digitalis Ventures, Euclidean Capital, Alexandria Venture Investments, and YK Bioventures. Other investors also participated in the round. The round was part of a larger USD 100 million seed and series A funding. As of 2024, Rajiv Patni is leading the firm as CEO.

Judo Bio's primary offering includes ligand-siRNA conjugates that enable receptor-mediated uptake in the kidneys. This novel technology leverages the kidney's physiology, particularly its recycling receptors, for the precision of drug delivery. The company's pipeline focuses on targeting solute carrier proteins within the nephron, making strides in developing treatments for both systemic and renal conditions.

The company plans to use the October 2024 funding to advance its lead ligand-siRNA conjugate into clinical trials and further develop its STRIKE platform.

## Funding rounds

- Series A, Jul 31, 2024, $25M — Atlas Venture, Alexandria Venture Investments, The Column Group, Euclidean Capital, Digitalis Ventures, Droia Ventures, YK Bioventures
- Seed, Nov 22, 2022, $20M — Atlas Venture, The Column Group

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Seed, Series A
- The Column Group (https://capitalatlas.ai/funds/the-column-group) — Seed, Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Euclidean Capital — Series A
- Digitalis Ventures (https://capitalatlas.ai/funds/digitalis-ventures) — Series A
- Droia Ventures (https://capitalatlas.ai/funds/droia-ventures) — Series A
- YK Bioventures (https://capitalatlas.ai/funds/yk-bioventures) — Series A